These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8205741)

  • 1. Hemodynamic effects of lipo-PGE1 on peripheral artery in patients with diabetic neuropathy: evaluated by two-dimensional color Doppler echography.
    Okuda Y; Mizutani M; Ogawa M; Sone H; Asano M; Tsurushima Y; Morishima Y; Asakura Y; Suzuki S; Isaka M
    Diabetes Res; 1993; 22(2):87-95. PubMed ID: 8205741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
    Hoshi K; Mizushima Y; Kiyokawa S; Yanagawa A
    Drugs Exp Clin Res; 1986; 12(8):681-5. PubMed ID: 3757764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
    Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y
    Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy.
    Okuda Y; Mizutani M; Ikegami T; Ueno E; Yamashita K
    Arzneimittelforschung; 1992 Apr; 42(4):540-2. PubMed ID: 1642679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipo-prostaglandin E1 increases immediate arterial maximal flow velocity of free flap in patients undergoing reconstructive surgery.
    Jin SJ; Suh HP; Lee J; Hwang JH; Hong JPJ; Kim YK
    Acta Anaesthesiol Scand; 2019 Jan; 63(1):40-45. PubMed ID: 30058113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a single drip infusion of lipo-prostaglandin E1 on vibratory threshold in patients with diabetic neuropathy.
    Tawata M; Nitta K; Kurihara A; Nagasaka T; Iwase E; Gan N; Inoue M; Onaya T
    Prostaglandins; 1995 Jan; 49(1):27-39. PubMed ID: 7792389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and hemodynamic effects of lipo PGE1 in cerebral infarction].
    Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
    No Shinkei Geka; 1988 Jun; 16(7):819-26. PubMed ID: 3221965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy.
    Hong L; Zhang J; Shen J
    J Diabetes Complications; 2015; 29(8):1283-6. PubMed ID: 26355026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic effect of lipo PGE1 on diabetic neuropathy-changes in endothelin and various angiopathic factors.
    Itoh Y; Yasui T; Kakizawa H; Makino M; Fujiwara K; Kato T; Imamura S; Yamamoto K; Hishida H; Nakai A; Itoh M; Nagasaka A
    Prostaglandins Other Lipid Mediat; 2001 Oct; 66(3):221-34. PubMed ID: 11577785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGE1 improves diabetic peripheral neuropathy in patients with type 2 diabetes.
    Wu JD; Tao S; Jin X; Jiang LL; Shen Y; Luo Y; Zhang P; Lee KO; Ye L; Ma JH
    Prostaglandins Other Lipid Mediat; 2016 Nov; 126():24-28. PubMed ID: 27421690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.
    Mizushima Y; Shiokawa Y; Homma M; Kashiwazaki S; Ichikawa Y; Hashimoto H; Sakuma A
    J Rheumatol; 1987 Feb; 14(1):97-101. PubMed ID: 3553591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of lipo-prostaglandin E1 on axial pattern flaps in rabbits.
    Kuwahara H; Fazhi Q; Sugihara T; Ohura T; Igawa H; Yamamoto Y
    Ann Plast Surg; 1995 Dec; 35(6):620-6. PubMed ID: 8748345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lipo-prostaglandin E1 on pulmonary hemodynamics and clinical outcomes in patients with pulmonary arterial hypertension.
    Shen J; He B; Wang B
    Chest; 2005 Aug; 128(2):714-9. PubMed ID: 16100159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake by vascular smooth muscle cells plays an important role in targeting of lipid microspheres incorporating prostaglandin E1 into a thickened intima.
    Chino Y; Minagawa T; Kohno Y; Toda Y; Murakami S; Higuchi S
    Life Sci; 2001 Jan; 68(8):933-42. PubMed ID: 11213363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of alprostadil (prostaglandin E1) incorporated in lipid microspheres of soybean oil on intimal hyperplasia following balloon injury in rabbits.
    Kunihara M; Tsuchida K; Kaneko K; Suga H; Hasegawa T; Mochizuki S; Kawai K; Shiga A; Yamaguchi T
    Arzneimittelforschung; 2002; 52(5):358-64. PubMed ID: 12087920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prostaglandin E1.alpha CD on vibratory threshold determined with the SMV-5 vibrometer in patients with diabetic neuropathy.
    Shindo H; Tawata M; Inoue M; Yokomori N; Hosaka Y; Ohtaka M; Onaya T
    Diabetes Res Clin Pract; 1994 Jul; 24(3):173-80. PubMed ID: 7988349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between non-ionic contrast medium and prostaglandin E1 incorporated in lipid microspheres: in-vitro comparative study of direct and non-direct mixing.
    Hayashi H; Uchiyama N; Kawamata H; Takagi R; Abe Y; Kumazaki T
    Radiat Med; 2000; 18(4):219-25. PubMed ID: 11246996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of established collagen induced arthritis with prostaglandin E1 incorporated in lipid microspheres.
    Moriuchi-Murakami E; Yamada H; Ishii O; Kikukawa T; Igarashi R
    J Rheumatol; 2000 Oct; 27(10):2389-96. PubMed ID: 11036835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumlation of lipoprostaglandin E1 at the anastomotic region after systemic application.
    Okochi M; Ueda K; Kajikawa A
    Microsurgery; 2011 Jul; 31(5):382-7. PubMed ID: 21618280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.